samedan logo
 
 
spacer
home > pmps > spring 2002 > ontario - setting the pace in biotech and pharma discovery, development and manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Ontario - Setting the Pace in Biotech and Pharma Discovery, Development and Manufacturing

I visited Toronto in February at the invitation of the Ontario Government's Ministry of Economic Development and Trade (MEDT) to report on significant developments in the health care industry in Ontario, Canada.


Ontario is Canada's largest province with over 11 million people - 33,000 of these working in the biomedical industry. It has a highly educated and skilled workforce. Ontario's 17 universities produce more than 17,000 graduates a year in maths, engineering, sciences and health professions. Ontario has a number of vibrant medical and academic centres. These areas are located in Toronto, one of North America's largest centres of biomedical activity; Ottawa, with particular strengths in nuclear medicine, cardiovascular devices, biochips, therapeutics and bioinformatics; London, another area of biomedical activity well-known for its expertise in medical imaging; Hamilton, an up-and-coming biomed centre, renowned as a site for clinical research; and Kingston, another emerging biomed centre.

The Toronto area is home to more than 100 biomedical companies, including global leaders like GlaxoSmithKline, Amgen, AstraZeneca, Bayer Corporation, Biogen, Boehringer Ingelheim, Eli Lilly, Novartis, Novopharm, Pfizer, Aventis Pasteur, Biovail Corporation, GE Medical Systems and Johnson & Johnson Medical Products.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Editor of PMPS
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

FT Global Pharmaceutical and Biotechnology Conference 2008

2-3 December 2008, The Cumberland, London

FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >>

 
News and Press Releases

Financial Times hosts the Global Pharmaceutical and Biotechnology Conference

13th November 2008
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement